\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes SecurityOne of the main new policies currently under development is the new European pact on asylum and migration.
This was proposed on the 23rd of September and is planned to be adopted in Q2 of 2021.
With the new approach, the European Commission wants to solve issues surrounding migration the EU has encountered over the last five years. A very detailed website is set up which is essential reading for those parties who will want to submit migration and border control projects under Horizon Europe.
The website can be found here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
